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Abstract 
 
In the pharmaceutical industry, there is an increasing demand for rapid screening assays with 
a good predictivity for the regulatory tests. The Comet assay, or Single Cell Gel 
Electrophoresis Assay, is a fast, easy and relatively inexpensive method to visualize and 
measure DNA strand breaks in individual cells. In the early drug development, when the 
amount of the test substance is limited, the Comet assay must fulfil several criteria. 
  
Since DNA damage is associated with cell death, cytotoxicity measurements should be 
evaluated concurrently with each Comet experiment. The purpose of the present study was to 
find a suitable cytotoxicity test in mouse lymphoma L5178Y (ML) cells and evaluate a high-
throughput variant of the alkaline Comet assay (HT-ACA) in the same cell line. A modified 
protocol for the Comet assay, with inclusion of commercially available multi-well object 
slides was tested. The HT-ACA experiments were performed with four alkylating agents and 
the obtained results were then compared to Comet assay data previously obtained by the 
standard HT-ACA protocol of Comet Assay, currently in use at Safety Assessment, 
AstraZeneca. 
 
Based on the results from experiments with different cytotoxicity tests, measurement of ATP 
levels was chosen as a suitable test in ML cells. The observed LOELs obtained from the 
modified HT-ACA were in good accordance with the standard HT-ACA protocol, albeit some 
differences were revealed. For instance, the modified version detected positive genotoxicity in 
concentrations two to five times lower than earlier had been found with the standard HT-ACA 
protocol. Even though the Comet assay has the potential to become a powerful complement to 
other genotoxicity tests, there are some bottlenecks in its performance, which need to be 
addressed. 
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1. Abbreviations  
 
B(a)P   Benzo(a)pyrene 
DMBA  9,10-dimetyl-1,2-benzanthracene 
EthD-1  Ethidium homodimer-1 
G6PD   Glucose 6-Phosphate Dehydrogenase 
HT-ACA  High-throughput alkaline Comet assay 
LMP agarose  Low Melting Point agarose 
LOEL   Lowest-Observed-Effect-Level 
ML cells  Mouse Lymphoma L5178Y cells 
MMC   Mitomycin C 
NDCN   Non-Detectable Cell Nuclei 
NNP   N-nitrosopiperidine 
4NQNO  4-nitroquinoline-N-oxide 
SAS   Safety Assessment Sweden 
TBDE   Trypan Blue Dye Exclusion 
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2. Preface 
 
This study is my graduate project for a Master of Science degree in Biology at the Swedish 
University of Agricultural Science, Uppsala. The study was conducted at the Department of 
Genetic Toxicology, Safety Assessment R&D, AstraZeneca, Södertälje. The project is a part 
of developing a standardized protocol for the high-throughput variant of the Comet assay 
intended for use in the standard battery of genotoxicity tests performed at AstraZeneca. 
Examination of this project was performed at the Department of Biomedical Sciences and 
Veterinary Public Health, Division of Pathology, Pharmacology and Toxicology, SLU, 
Uppsala.   
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3. Introduction 
  
Different kind of DNA damages e.g. point mutations, DNA-DNA or DNA-protein crosslinks 
and single or double strand breaks may appear when cells are exposed to genotoxic 
substances (Marzin 1999, Garberg et al. 1988). The DNA damage is one of the main events 
that give rise to mutations and chromosome brakeage, which might lead to development of 
cancer (Christmann et al. 2003). By monitoring DNA strand breaks as an indicator, potential 
genotoxic compounds can be discovered (Garberg et al. 1988).  
 
In the pharmaceutical industry, there is an increasing demand for rapid screening assays with 
a good predictivity for the regulatory tests. A recent study by Kiskinis et al. has indicated that 
the Comet assay has the potential to become such an assay, especially during the early drug 
development when the amount of test substance is limited. This kind of genotoxicity tests are 
generally conducted between discovery and development phases.  
 
Today, the pharmaceutical industry uses a battery of tests when test substances are analyzed 
for genotoxicity. These tests include two in vitro (the Ames test and the mouse lymphoma TK 
locus forward-mutation assay) and one in vivo test (the micronucleus assay). In case of 
equivocal or contradictory results from the standard test battery, other genotoxicity tests may 
be used for further evaluation.  
 
The Comet assay, or Single Cell Gel Electrophoresis Assay, is a quick, simple and relatively 
inexpensive method to visualize and measure DNA strand breaks in individual cells. After 
exposure to chemicals, cells are embedded in agarose on a microscope slide and immersed in 
a lysis solution to remove lipids and proteins. DNA is then allowed to unwind under alkaline 
conditions. Thereafter an electrophoresis is run to attract broken, negatively charged DNA 
towards the anode. This will shape a “comet-like” figure with a distinct head and a tail, which 
contains the damaged or broken pieces of DNA. After staining with a fluorochrome (e.g. 
ethidium bromide), individual cells can be visualized in a fluorescent microscope (Marzin 
1999, Comet Assay Interest Group 051201). A schematic overview of the Comet assay is 
provided in Figure 1.   
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In the agarose, cells form a cavity that after lysis is occupied by the DNA. Other biomolecules 
in the cell do not have the same high molecular weight as DNA and will hence diffuse 
through the agarose gel from the cavity into the lysis solution. The theory behind the 
migration of DNA is that when an electrical field is applied DNA is stretched out toward the 
anode but will still be fixed in the cavity. If DNA strand breaks are introduced the super-
coiling of the DNA is relaxed and will provide a more distinct migration (Comet Assay 
Interest Group 051201, Ostling & Johanson 1984). DNA damage must therefore be converted 
into strand breaks that relax the supercoiled DNA or produce DNA fragments before detected 
in the Comet assay (Comet Assay Interest Group 051201).    
  
 
 
Figure 1: Methodology of the Comet assay. The alkaline variant on the right hand was used throughout the study 
(Comet Assay Forum 051207). 
   
Individual digital images of cells in the Comet assay are captured, whereafter a variety of 
comet parameters can be analysed e.g. tail length, tail DNA content, tail moment etc. These 
parameters indicate the number of strand breaks present in the cell i.e. the higher the breakage 
frequency the more DNA is present in the tail of the comet (Marzin 1999). Hence 
genotoxicity is detected as an increase in a particular comet parameter e.g. the median comet 
length (Frei et al. 2001, Collins & Harrington 2002).            
  
The Comet assay has become very popular due to its ability to measure DNA damage in 
almost any population of monodispersed cells and can be used under both in vitro and in vivo 
conditions (Frei et al. 2001, Andersson et al. 2003 and Singh et al. 1994). Modifications of 
the original method described by Ostling and Johanson have extended the types of DNA 
 7
 
damage that can be detected with this technique (Collins & Harrington 2002, Singh et al. 
1994). In addition to single-stand breaks (SSB), the Comet assay can be used to detect 
double-strand breaks (DSB), alkali-labile sites (ALS), damage to DNA bases, DNA-DNA or 
DNA-protein cross-linking plus apoptotic fragments (Tice et al. 2000). The extent of DNA 
migration (tail length, % DNA in the tail) is generally believed to be related directly to 
fragment size and would be expected to be proportional to the frequency of strand breaks and 
ALS, and inversely proportional to the extent of DNA cross-linking (Comet Assay Interest 
Group 051201, Tice et al. 2000).       
  
There are several variants of the Comet assay employing different pH conditions during 
unwinding and/or electrophoresis. DSB are the simplest DNA damage detected by the Comet 
assay and can easily be discovered by electrophoresis at neutral pH (7-8). SSB can not be 
produced unless the DNA strands are denatured. Therefore, unwinding the DNA at alkaline 
conditions (pH of 12.1-12.5) and subsequently an electrophoresis run at the same pH, allows 
the detection of SSB, cross-links and DSB. At pH >13, the assay detects SSB, DSB, ALS 
(which are transformed into SSB) and cross-linking (Comet Assay Interest Group 051201).  
  
Since DNA damage is associated with cell death, cytotoxicity measurements should be 
evaluated concurrently with each Comet experiment. It may also be helpful, prior to the 
Comet experiment, to perform a preliminary range finding experiment with a cytotoxicity 
assay. There are a number of cytotoxicity methods to use either at the end of the exposure 
period (e.g., exclusion of a vital dye, ATP levels, release of various enzymes from the 
cytoplasm) or after certain incubation period for recovery (e.g., cell count). The general 
approach is to avoid proceeding with samples in the Comet assay that decrease viability 
(assessed by the trypan blue dye exclusion method) by more than 30% when compared to the 
concurrent control (Tice et al. 2000).   
  
In the present study, experiments with different cytotoxicity assays were performed in mouse 
lymphoma L5178Y (ML) cells. Thereafter, one of these tests was chosen to proceed to 
comparison experiments with the traditionally used trypan blue dye exclusion (TBDE) 
method. In addition, the concept of 96-well Comet assay, so called high-throughput variant of 
the alkaline Comet assay (HT-ACA), have been further developed in ML cells. The protocol 
of Kiskinis et al. was modified by inclusion of commercially available multi-well object 
slides instead of one sample per object slide. The modified protocol was tested with four 
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alkylating agents as test compounds. The obtained results were then compared to Comet assay 
data that were previously obtained by the standard HT-ACA protocol of Comet assay, 
currently in use at Safety Assessment Sweden (SAS). 
  
4. Aims 
 
The project was divided into two parts. The aim of the first part was to find a suitable 
cytotoxicity test in ML cells among three commercially available kits. These tests measures 
different biological markers, which are related to cytotoxicity. The most suitable of these tests 
was chosen for further evaluation experiments against the traditionally used TBDE method. 
Compounds with different cytotoxic effect were used in these experiments.  
 
The aim of the second part was to compare results from the modified HT-ACA and the 
standard HT-ACA protocol of Comet assay in ML cells. The amount of the test substance is 
limited during the early drug development and therefore the Comet assay must fulfill several 
criteria to be useful as an in vitro screening assay. These criteria are listed below. 
 
? Adaptability to a high-throughput format − preferably in a standard 96-well format 
that might be suitable for automation 
? Simple and quick protocol − the assay should ideally be carried out by one person 
? Reliability, versatility, low inter-experiment variability – standardized protocol and 
reagents, evenly (if possible) distributed workload 
? Concurrent determination of cytotoxicity − must match the throughput of the Comet 
assay, be biologically relevant for the tested cell type and if possible allow 
simultaneous detection and discrimination of both apoptotic and necrotic events 
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5. Materials and methods 
5.1. Cells and culture conditions 
  
Mouse lymphoma L5178Y TK+/- cells, subline 3.7.2C, were obtained from Dr. D. Clive, 
Burroughs Welcome Co., Research Triangle Park, N.C., USA and kept at -196°C. The cells 
were cultured in RPMI 1640 medium supplemented with PSGP (penicillin, streptomycin, L-
glutamine and Na-pyruvate), 10% heat inactivated horse serum and Pluronic F68 from Gibco 
(Gaithersburg, MD) at +37°C in a humidified air incubator (95% relative humidity and 5% 
CO2) using 80cm2 cultivation flasks. A new culture was started every week from a fresh 
ampoule to minimize variations in the experiments due to differences in generation time and 
spontaneous mutations. Every working day the cell concentration in the ongoing culture was 
adjusted to cells/mL. Cell concentration was measured with BECKHAM COULTER41015 ⋅ ® Z2 
Particle Count and Size Analyzer. During experiments the cell suspensions contained growth 
media complemented with only 3% heat inactivated horse serum (end concentration in 
culture). 
 
5.2. Materials 
 
Detailed buffer compositions and other solutions used throughout the experiments are 
provided in the Appendix. CellTiter-Glo® Luminescent Cell Viability Assay was purchased 
from Promega. Vybrant™ Cytotoxicity Assay Kit and LIVE/DEAD® Viability/Cytotoxicity 
Kit for mammalian cells were obtained from Invitrogen. Double-distilled water was used all 
the way through the experiments. Other chemicals used in the study were of analytical grade 
and obtained from regular commercial sources.  
 
Two different groups of compounds were used during comparison tests between ATP levels 
and TBDE, an alkylating agent (see below) in the presence and absence of metabolic 
activation and two aneugens (Figure 2). Aneugens inhibit cell division and cause cytotoxicity 
by interfering with the processes of mitosis and meiosis, without interacting with the DNA. 
They act by binding to tubulin and inhibiting its polymerization into microtubules, which 
prevent spindle formation in dividing cells and causes arrest at metaphase. They also inhibit 
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other cellular activities that involve microtubules like migration and transport (Rang et al. 
2003, Timbrell 2001).   
 
In evaluation experiments of the modified HT-ACA, test compounds with a variety of 
genotoxic effects were used (Figure 2). For some compounds, metabolic activation was 
needed. Alkylating agents contain chemical groups (alkyl groups) that cause DNA damage 
when interacting covalently with bases of the DNA. The alkyl group reacts preferably with 
nucleophilic oxygen and nitrogen atoms in the DNA molecule. Most agents have two 
alkylating groups, so called bifunctional alkylating agent, and can cross-link two nucleophilic 
sites and cause intra- or interchain cross-linking. This can interfere with transcription and 
replication (Rang et al. 2003, Timbrell 2001).  
 
              
                 
                                                                              
Figure 2: Chemical structure of test compounds used in evaluation experiments. At the top, starting form left: 
aneugens (colchicine, carbendazim), alkylating agents (NNP, B(a)P and DMBA). At the bottom, from left; 
alkylating agents (4NQNO) and bifunctional alkylating agent (MMC).  
 
The S9 liver homogenate was prepared according to the method of Majeska and Matheson 
and was stored frozen at or below -70°C until use. The cofactor mix (see Appendix) was 
sterilized by filtration through a 0.2 μm Millipore filter and stored frozen at -80°C until use. 
On the day of treatment, the protein content was adjusted to 30 g/L by dilution with R0P 
before it was blended with the cofactor mix according to standard operating procedures at 
SAS (23 mL cofactor mix to 2 mL S9). The end concentration of S9 fraction in the cultures 
was 4%.    
 
Incubation of cells was performed in 96-well microplate (Costar 3585) and luminescence and 
fluorescence measurements were conducted in FluoroNunc™/LumiNunc™ 137101. 
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5.3. Treatment of cells  
 
Treatment of cells with the test compounds were all performed in 96-well microplates, with or 
without S9-mix. The plates contained series of concentrations of the test compound dissolved 
in DMSO (end concentration in culture 1%) or water. As controls served cells exposed to the 
solvent without test compound. The plate was incubated for 3 hours at +37°C on a tilted table 
in a humidified air incubator with 5% CO2. During experiments with cytotoxicity assays some 
incubation periods were set to 10 minutes or 24 hours. In evaluation of cytotoxicity tests a 
heat-induced cell death experiment was conducted according to Van der Waal et al. The heat 
treatments were aimed to induce apoptosis and necrosis, thus inducing distinct difference in 
ATP levels. The ML cells were incubated at +43°C for 24 minutes or +45°C for 30 minutes 
that should result in the two processes of apoptosis and necrosis, respectively. After the heat 
induction, cells were incubated for 2.5-3 hours in +37°C in a humidified air incubator and 
results were compared to controls only exposed to +37°C.       
 
The treatment of cells was optimized with respect to cell concentration and the end 
concentration of DMSO in culture. Too high cell density in the Comet assay would lead to a 
harder time to find and score individual cells. On the other hand, if the cell concentration was 
too low it took a lot of time to search for the widely spread cells. The final concentration of 
DMSO was chosen to 1%, because that concentration caused no cell toxicity. 
 
In the experiments with the test compounds, dilution series were used. The dilution factor 
between stock 1 and 2 was 1.5. Two series of five concentrations with a 2-fold spacing were 
prepared from each stock solution. Aliquots of 200 μL, or 100 μL if metabolic activation was 
needed, of stock 1 and stock 2 were placed in all wells in columns 3 and 8. The remaining 
wells, except column 2, were filled with growth media without serum, 100 μL or 50 μL if S9-
mix was required. 1:2 dilutions of the stock solutions were performed from column 3 to 7 and 
from column 8 to 12, using a multi-tip pipette, as described in Figure 3. Finally, 100 μL cell 
suspension ( cells/mL), or 70 μL cell suspension ( cells/mL) in growth media 
complemented with 3% serum (end concentration in culture) along with 80 μL S9-mix, were 
added to all wells except column 2. The total volume in each well was 200 μL and the final 
cell concentration was cells/mL.  
41048 ⋅ 41070 ⋅
41024 ⋅
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   Dilution 1:2, use multi-tip pipette 
 
                 waste              waste 
 
1     2     3     4     5     6      7     8     9    10    11   12 
A 
B
C
  
  
 
 
D 
E
F
G 
H 
 
 
 
 
 
 
                  control      empty       Stock 1                           Stock 2 
 
Figure 3: Layout of 96-well microplate. Two stock solutions were prepared for every test compound. The 
picture is based on information from Kiskinis  et al. 
 
5.4. Cytotoxicity assays 
5.4.1. Vybrant™ Cytotoxicity Assay Kit 
 
The Vybrant™ Cytotoxicity Assay Kit monitors the release of the cytosolic enzyme glucose 6-
phosphate dehydrogenase (G6PD) from damaged cells into the surrounding medium. G6PD 
catalyzes the reaction of NADP to its reduced form, NADPH, in the pentose phosphate 
pathway. The assay detects G6PD through a two-step enzymatic reaction that leads to the 
reduction of resazurin into red-fluorescent resorufin (Figure 4) measured by microplate 
spectrophometer (Spectramax M2, Molecular Devices). The fluorescence signal is pro-
portional to the amount of G6PD released into the cell medium, and this release correlates 
with the number of dead cells in the sample (Product Information V-23111, Frank 2005). 
During exposure, all cell cultures contained 0.5 2.5 cells/well in growth media. 
According to the manufacturer, the recommended cell concentration was between 500 and 25 
000 cells/well. In experiments with Vybrant
−⋅ 410 410⋅
™ Cytotoxicity Assay Kit, the manufacturer’s 
protocol was optimized in ML cells (e.g. cell concentration, incubation times, excitation and 
emission wavelengths). Tests with DMSO, a frequently used solvent for many of the test 
chemicals used in this study, was also investigated for its possible interaction with reagents in 
the assay. Experiments showed that DMSO interacted with reagents in the Vybrant™ 
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Cytotoxicity Assay in a way that was not related to immediate cell toxicity, already at 10 
minutes incubation time (with DMSO). Thus, the interference of DMSO with the enzymatic 
reaction was significant already at the concentration of 1 %, which is the regular final 
concentration of DMSO during the exposure period in the Comet assay.   
 
6-phosphogluconate 
Resazurin Resorufin 
Diahorase 
 
NADPH NADP+ 
Glucose 6-phosphate  
Dehydrogenase
Glucose 6-phosphate 
 
 
 
 
 
 
 
 
 
Figure 4: Principle of the two-step enzymatic assay for detection of glucose 6-phosphate dehydrogenase. 
Oxidation of glucose 6-phosphate by glucose 6-phosphate dehydrogenase results in the generation of NADPH, 
which in turn leads to the reduction of resazurin by diaphorase to yield fluorescent resorufin.  
  
5.4.2. LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells 
 
The LIVE/DEAD® Viability/Cytotoxicity Kit for mammalian cells distinguishes between live 
and dead cells with two probes (calcein AM and ethidium homodimer-1) that measure 
intracellular esterase activity and plasma membrane integrity, respectively. Live cells were 
detected due to the presence of ubiquitous intracellular esterase that catalyses the conversion 
of the non-fluorescent calcein AM to the intensely fluorescent calcein. Calcein AM can cross 
an intact plasma membrane and the polyanionic dye calcein is well retained within live cells, 
producing an intense stable green fluorescence in live cells. Ethidium homodimer-1 (EthD-1) 
enters the damaged membranes of dead cells. Binding to nucleic acids of the probe produces a 
bright red fluorescence in dead cells (Product Information 03224). The fluorescence signals of 
the reactions were measured by microplate spectrophometer (Spectramax M2, Molecular 
Devices). Different cell concentrations were used during the experiments ranging between 
0.5 cells/well. Manufacturer recommended minimum 200-500 cells/well and not 
more than cells/well. Excitation and emission spectra were analysed to locate optimal 
wavelengths for the fluorescent dyes in experiments with LIVE/DEAD
44 102510 ⋅−⋅
610
® Viability/ 
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Cytotoxicity Kit. They were determined to be 485/530 nm for calcein and 544/645 nm for 
EthD-1. The assay was performed in two steps. First, the presence of live and dead cells was 
determined by measuring the calcein and EthD-1 signals, respectively. Afterward, the total 
number of cells in the sample was revealed by lysis of all cells with 0.1% saponin. The 
overall results of pilot experiments with this assay were deemed as unsatisfactory. Addition of 
saponin to the cell suspension resulted only in a slight increase of the EthD-1 signal (results 
not shown). Moreover, serum-supplemented growth media can cause an increase in 
background caused by extracellular fluorescence due to hydrolysis of calcein AM. This means 
that cells have to be washed prior to the assay to remove or dilute serum esterase activity. The 
assay also includes an incubation period of 30-45 minutes after adding the reagents for 
stabilization of the signal. If this incubation occurs in D-PBS or HBSS, after attempts to 
remove serum from the cells, previous studies at SAS have shown that the condition becomes 
cytotoxic for the ML cells.   
 
5.4.3. CellTiter-Glo™ Luminescent Cell Viability Assay 
 
The regents of CellTiter-Glo™ assay were combined with cell samples according to the 
instructions of the manufacturer. This assay measures the ATP level which is used as an 
indicator for the presence of metabolically active cells. The reagent generates cell lysis and 
produces a luminescent signal proportional to the amount of ATP present. The amount of 
ATP is directly proportional to the number of cells present in culture. The luciferase reaction 
for the assay is shown in Figure 5 (Technical Bulletin No. 288).  
 
 
Figure 5: The luciferase reaction. Oxygenation of luciferin is catalyzed by luciferase in the presence of Mg2+, 
ATP and molecular oxygen (Technical Bulletin No. 288). 
 
During exposure, all cell cultures contained 0.5 cells/well. According to the 
manufacturer, there is a linear relationship (R=0.99) between 0 and 50 000 cells/well in the 
96-well format. The luminescence of the ATP-releasing reaction was detected by a microplate 
luminometer (Luminoscan Ascent; Labsystems). In the experiments with heat-induced cell 
44 10410 ⋅−⋅
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death a significant decrease of ATP levels were observed in the cells exposed to +45°C but no 
significant differences were observed between the control cells and cells pre-incubated at 
+43°C. The relationship between luminescence signal and cell concentration was found to be 
linear (R2=1.00) in cell concentrations between 0.5  and 4 cells/well (results not 
shown).  
410⋅ 410⋅
 
5.4.4. Choice of cytotoxicity assay 
 
Based on the results of pilot experiments the assay measuring ATP levels was chosen as a 
suitable cytotoxicity test in ML cells before the other two assays. It is more sensitive, faster 
and easier to perform and seems to be gentler to the ML cells. Whereas ATP levels reflect 
cytotoxic events both in presence and absence of membrane damage, the other two assays are 
limited to detection of membrane damage. Moreover, in the Vybrant™ assay, DMSO showed 
direct interference with the assay components regardless of incubation time. Furthermore, the 
prolonged incubation of ML cells in HBSS or D-PBS during the LIVE/DEAD® method is 
cytotoxic per se.   
 
5.4.5. TBDE 
 
In the TBDE method, cell samples were mixed with an equal volume of 0.4% trypan blue and 
counted in a light microscope. Cells with a ruptured membrane allowed dye uptake and was 
considered dead.   
 
5.5. HT-ACA 
 
Concentrations of test compounds that continued to genotoxicity tests in the Comet assay 
were selected after cell viability determination at the end of the 3 hours exposure. Hence, 100 
μL of all cell samples were transferred from the 96-well incubation microplate to a new 96-
well plate for measurement of cytotoxicity. According to Kiskinis et al. concentrations 
resulting in <70% (TBDE test) or <50% (ATP test) relative viability were considered to have 
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a too high cytotoxicity for analysis in the Comet assay. These thresholds were applied in this 
study.  
 
The selected samples were transferred from the 96-well incubation microplate to Eppendorf 
tubes and washed in PBS once. Thereafter, the cells were mixed 1:10 with Trevigen 
LMAgarose and placed on slides. Two protocols for preparation of Comet slides for the HT-
ACA were used (A and B). Protocol A was compared with B which is the standard HT-ACA 
protocol used at SAS.  
 
In protocol A, 20-well object slides (Trevigen), already pre-coated by the manufacturer, were 
used. 30 μL of the agarose-cell suspension were applied per well on pre-coated 20-well slides. 
About 7 000 cells/well were used in each experiment.  
  
In protocol B, frosted microscope slides (Erie Scientific Company) were pre-coated with 1% 
agarose (400 μL). The excess agarose was scraped off and a bottom gel with 0.6% agarose 
(100 μL) was added. Thereafter, about cells were embedded in 0.6% low 
melting point (LMP) agarose on the slides and finally a top gel of 0.6% LMP agarose (75 μL) 
was layered on top.    
44 107102 ⋅−⋅
 
The slides, from both protocols, were dried at +4°C until a 0.5 mm clear ring appeared at the 
edge of the sample area. Slides were placed in lysis solution for at least one hour at +4°C. The 
lysis solution used in protocol A was a pre-made Trevigen Lysis Solution and the composition 
of the lysis solution used for protocol B is specified in Appendix. After lysis the slides were 
placed in a horizontal gel electrophoresis unit in which the DNA samples were left to unwind 
at room temperature for 30 minutes in freshly prepared alkaline electrophoresis buffer pH >13 
(see Appendix). The electrophoresis was run at room temperature for 20 minutes using field 
strength of 0.7 V/cm (301 mA, 25 V). Following electrophoresis, the slides were neutralised 
in neutralization buffer for 3x5 minutes and left to air-dry in room temperature. In protocol A, 
samples were also dehydrated in 70% ethanol for improved drying out. Before scoring, the 
dried microscope slides were stained with 5 μL/well of 20 μg/mL ethidium bromide in 
protocol A and 50 μL/slide in protocol B. The slides were stored at +4°C for at least 
30 minutes before image analysis was performed. All steps from lysis until the end of the 
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image analysis were performed under reduced light in order to avoid unspecific DNA damage 
from UV light. 
   
5.6. Image analysis 
 
Slides were examined at 25x magnification in a fluorescence microscope (Leitz DIALUX 
22EB) equipped with an excitation filter (515-560 nm) and a barrier filter (590 nm). Digital 
images were captured by a black and white charge-coupled device video camera (Ikegami) 
attached to the microscope and transferred to a PC-based image analysis system 
(Colourmorph v5.0; Perceptive Instruments, UK). Fifty “comets” per sample were randomly 
selected, avoiding the edges and eventually damaged parts of the gel, debris, superimposed 
comets and comets without a distinct “comet head” (i.e. so called “non-detectable cell nuclei” 
(NDCN), “clouds”, “hedgehogs” or “ghost cells”). NDCN or “clouds” are cells exhibiting 
extensive DNA fragmentation to a point where no clear head/nucleus but only the tail is 
visible, most likely representing dead or dying cells. Albeit NDCN were excluded from the 
image analysis, their frequency was determined for each sample and used as an additional 
indicator of cytotoxicity. 
 
5.7. Evaluation criteria 
  
Based on extensive historical data of negative and positive controls, evaluation criteria for 
genotoxicity (positive, negative, equivocal) of the tested chemical in the Comet assay have 
been previously established (unpublished data, AstraZeneca). The protocol tested for the 
purpose of the modified HT-ACA differed only in the procedure of object slide preparation. 
As the conditions of lysis, unwinding and electrophoresis (steps with major influence on the 
obtained results) were similar for both protocols, the assumption that the evaluation criteria 
for protocol B (see below) could be applied also for protocol A. No formal statistical analysis 
was performed of the results. Significance levels were judged as obvious increase/decrease of 
a particular parameter.  
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1) A test chemical was considered to be positive  
a) If it produces an increase in the tail length of more than 6.0 μm or/and if the tail 
moment was more than 0.500 μm or/and if the fraction of DNA damaged cells was 
16% or more compared with the concurrent solvent control in either or all of the above 
mentioned parameters.  
b) And it these effects are seen at two or more concentrations of the test compound in at 
least one trial. 
c) And if a positive dose trend is seen in consecutive doses among the cells measured in 
at least one trial. 
d) And these effects are found at a relative toxicity of 30% or less measured with trypan 
blue exclusion method. 
e) And these effects are found where a sufficient number of living cells, i.e. more than 
approximately 30%, remain after treatment. 
f) And these effects are found where a sufficient number of cell nuclei, i.e. more than 
approximately 40%, could be scored for DNA damage analysis.  
 
2) A result was considered to be negative 
a) If no increase in tail length or tail moment were found and the test compound was 
tested up at least 10 mM. 
b) Or if the effects under 1a, 1b and 1c were found only at concentrations that give a 
relative toxicity of more than 30% measured with the trypan blue exclusion method 
or/and a relative decrease of ATP levels by more than 50%.  
c) Or if the effects under 1a, 1b and 1c were found only at concentrations where less than 
approximately 30% living cells remain after treatment. 
d) Or if the effects under 1a, 1b and 1c were found only at concentrations where less than 
approximately 40% of the cell nuclei could be scored for DNA damage. 
e) Or if the effects were only found at one concentration in one trail. 
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6. Results and discussion 
6.1. Comparison between TBDE and ATP  
  
A series of experiments were conducted for comparison between measuring ATP levels and 
the standard TBDE method. The aim of these experiments was to confirm the previously 
suggested 50% relative decrease of ATP as limiting cytotoxicity criteria in the Comet Assay 
(Kiskinis et al. 2002).  
 
ML cells were exposed to NNP, colchicine and carbendazim. NNP was tested with and 
without metabolic activation during 3 hours and the two aneugens were tested without 
metabolic activation during 24 hours. At the end of the incubation period the ATP levels were 
determined. Thereafter the membrane integrity of the cells was assessed with the TBDE 
method. Results are expressed as % ATP content of control for ATP measurement and % 
viable cells of control for the TBDE method. 
 
The correlation between measurement of ATP levels and the TBDE cytotoxicity data for NNP 
was good in the absence of metabolic activation since the criteria for both tests would have 
selected similar concentrations for further analysis in the Comet assay (Figure 6). In the 
presence of S9-mix there was a more rapid decrease. The decrease of the ATP levels was also 
dose-dependent. The highest dose would have been rejected according to the ATP levels. 
Based on the results of the TBDE method all doses would have been processed in the Comet 
assay (Figure 6). If the different results obtained with and without S9 mix is correct, the 
generally applied viability criteria, ≥70% (TBDE method) and ≥50% (ATP method), of the 
concurrent control should be changed. It should be noted, however, that in this experiment the 
activation system was not removed prior to ATP measurements. Hence the possible 
degradation of ATP due to presence of the S9-mix should be further evaluated in experiments.  
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Figure 6: Effects on viability of ML cells exposed to serial concentrations of NNP in the absence and presence 
of S9-mix for 3 hours. Viability is measured by ATP levels and TBDE method. Results are expressed as the 
mean percentage of control (mean; n=4 for ATP and mean; n=2 for TBDE). As controls served cells exposed to 
the solvent without test compound. 
 
The experiment with the two aneugens showed that values from both ATP levels and the 
TBDE method followed the same course in cells exposed to colchicine for 24 hours (Figure 
7). The lowest tested concentration was cytotoxic to the ML cells, but there was not any dose-
dependent increase in cytotoxicity. A putative explanation of these results could be the 
immediate cytotoxic effect of colchicine on a subpopulation of ML cells while exerting a 
mitotic block on the rest of the cells that is still present after 24 hours. In this context, the 
abnormal p53 status of the ML cells would hamper the induction of apoptosis, which 
normally is a common result of cell cycle disruptions (Sherwood et al. 1994). The correlation 
between the cytotoxicity data from the two tests is rather poor in this case. Based on the ATP 
levels data none of the concentrations would have moved on to genotoxicity test in the Comet 
assay. The TBDE method, on the other hand, would allow proceeding with almost all the 
doses.    
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Figure 7: Effects on viability of ML cells exposed to serial concentrations of colchicine for 24 hours. Viability is 
measured by ATP levels and TBDE method. Results are expressed as the mean percentage of control (mean; n=8 
for ATP and mean; n=2 for TBDE). As controls served cells exposed to the solvent without test compound. 
 
Incubation of ML cells with carbendazim at concentrations 15 μM and higher during 24 hours 
resulted in loss of viability, as shown in Figure 8. No loss of viability could be seen at lower 
concentrations according to the results of both cytotoxicity tests. The results are in good 
agreement with previously obtained data (Smith 2005), where a significant reduction in both 
relative suspension growth and TBDE values for carbendazim-treated ML cells was seen at 
the same concentration. Unexpectedly, these lower concentrations had a stimulatory effect on 
ATP levels as compared with the untreated controls. The counting of cells in light microscope 
revealed an increased cell number in lower concentrations.  
 
 22
 
020
40
60
80
100
120
140
160
180
200
0 1.25 1.875 2.5 3.75 5 7.5 10 15 20 30
Carbendazim (µM)
Vi
ab
ili
ty
 
(%
 o
f c
on
tr
ol
)
ATP
TBDE
Figure 8: Effects on viability of ML cells exposed to serial concentrations of carbendazim for 24 hours. Viability 
is measured by ATP levels and TBDE method. Results are expressed as the mean percentage of control (mean; 
n=8 for ATP and mean; n=2 for TBDE). As controls served cells exposed to the solvent without test compound. 
 
In summary, the comparison experiments showed a rather good agreement between TBDE 
method and ATP levels for assessment of cell viability. Based on the cytotoxicity data, 2/3 of 
the experiments showed that comparable doses would have proceeded to genotoxicity test in 
the Comet assay. While having a similar sensitivity, the time was reduced from a couple of 
hours for the TBDE method to only about 20 minutes to complete the measurement of ATP 
levels with CellTiter-Glo®.   
 
6.2. Evaluation of the HT-ACA 
 
4NQNO was the only test compound tested according to protocol B. In parallel with ATP 
measurements, cell viability for the three highest concentrations of 4NQNO (2.5, 3.5 and 5 
μM) was also assessed with the TBDE method (Figure 9). Concentrations above 2.5 μM 
resulted in a steep decrease in viability according to results from both viability tests. All 
concentrations, except 5 μM, moved on to genotoxicity test in Comet assay. Five μM was not 
chosen because earlier studies at SAS have showed increased damage in another genotoxicity 
test at this concentration. In that genotoxicity test, which is part of the standard battery at 
SAS, 1.5 μM of 4NQNO is used as positive control.  
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Figure 9: Effects on viability of ML cells exposed to serial concentrations of 4NQNO for 3 hours prior Comet 
assay. Viability is measured by ATP levels and TBDE method. Results are expressed as the mean percentage of 
control (mean; n=8 for ATP and mean; n=2 for TBDE). As controls served cells exposed to the solvent without 
test compound. 
 
DNA migration parameters showed a clear dose-dependent curve (Figure 10), especially for 
tail moment. The frequency of NDCN was non-significant. The observed LOEL value (0.219 
μM, tail moment) corresponds well with the historical value (0.250 μM)  
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Figure 10: Parameters obtained in the Comet assay according to protocol B. ML cells exposed to serial con-
centrations of 4NQNO for 3 hours. Results are expressed as the mean tail length and tail moment (mean ± SD; 
n=50 cells). As controls served cells exposed to the solvent without test compound.  
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 MMC was tested according to protocol A and was the only cross-linking agent used in this 
study. All concentrations of MMC, except for the highest one (800 μM), showed unchanged 
ATP levels as compared to the solvent control (Figure 11). All doses moved on to geno-
toxicity test in the Comet assay.  
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Figure 11: Effects on viability of ML cells exposed to serial concentrations of MMC for 3 hours prior Comet 
assay. The viability is measured by ATP levels. Results are expressed as the mean percentage of control (mean; 
n=5). As controls served cells exposed to the solvent without test compound. 
 
Results from the Comet measurements (Figure 12) indicate a slight increase of DNA 
migration in tail length for doses up to 50 μM and in tail moment up to 100 μM. At higher 
concentrations, a significant reduction of DNA migration was observed as compared to the 
solvent control. No NDCN were detected during analysis. Due to problems with gel slippage, 
only one sample for 68.75 μM was captured during image analysis. 
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Figure 12: Parameters obtained in the Comet assay according to protocol A. ML cells exposed to serial con-
centrations of MMC for 3 hours. Results are expressed as the mean tail length and tail moment (mean ± SD; 
n=50 cells). As controls served cells exposed to the solvent without test compound.  
 
The results are in accordance with the previously published data on the genotoxic properties 
of MMC (Warren et al. 1998). MMC is a cytotoxic chemotherapeutic agent that causes DNA 
damage in the form of DNA cross-links as well as a variety of DNA monoadducts. In 
addition, MMC is known to induce p53. As crosslinks represent about 10-15% of the total 
MMC adducts, it would seem likely that the observed increase of DNA migration at lower 
doses originates from the repair of DNA monoadducts. At higher doses the frequency of DNA 
crosslinks would reach a level where it would influence the migration of DNA from the 
nucleus. 
 
DT-diaphorase can reduce MMC to a reactive intermediate that is a bifunktional alkylating 
agent. This intermediate crosslinks  DNA and produces SSB (Parkinson 2001).  No activation 
system was used in this experiment consequently results may be different using an activation 
system.    
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B(a)P and DMBA were run together on the same 96-well plate during the experiments and 
they were the only compounds that were tested with metabolic activation. The cytotoxicity 
profiles for B(a)P and DMBA, as determined by ATP levels, are shown in Figures 13 and 14. 
Although already the lowest tested concentration (4.375 μM) of B(a)P  was moderately 
cytotoxic, increasing concentrations did not result in increasing cytotoxicity. All concen-
trations of B(a)P moved on to genotoxicity test in Comet assay. DMBA, on the other hand, 
became cytotoxic to the ML cells first at 20 μM, here increasing concentrations of the 
chemical were paralleled with steep decrease of the ATP levels. All concentrations, except 40 
and 60 μM, moved on to genotoxicity test in Comet assay. The highest dose, 60 μM, failed 
according to the evaluation criteria and 40 μM was not chosen because earlier studies have 
showed increased damage in another genotoxicity test at this concentration. 
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Figure 13: Effects on viability of ML cells exposed to serial concentrations of B(a)P in the presence of S9-mix 
for 3 hours prior Comet assay. The viability is measured by ATP levels from two independent experiments. 
Results are expressed as the mean percentage of control (mean; n≥4). As controls served cells exposed to the 
solvent without test compound.  
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Figure 14: Effects on viability of ML cells exposed to serial concentrations of DMBA in the presence of S9-mix 
for 3 hours prior Comet assay. The viability is measured by ATP levels from two independent experiments. 
Results are expressed as the mean percentage of control (mean; n≥3). As controls served cells exposed to the 
solvent without test compound.  
 
Comet data from protocol A for B(a)P and DMBA are shown in Figures 15 and 16. Both 
B(a)P and DMBA showed a slight dose-response curve in the Comet results. A few, up to 5%, 
NDCN were detected during analysis for both chemicals. 
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Figure 15: Parameters obtained in the Comet assay according to protocol A. ML cells exposed to serial con-
centrations of B(a)P for 3 hours in the presence of S9-mix. Results are expressed as the mean tail length and tail 
moment (mean ± SD; n=50 cells). As controls served cells exposed to the solvent without test compound.  
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Figure 16: Parameters obtained in the Comet assay according to protocol A. ML cells exposed to serial con-
centrations of DMBA for 3 hours in the presence of S9-mix. Results are expressed as the mean tail length and 
tail moment (mean ± SD; n=50 cells). As controls served cells exposed to the solvent without test compound.  
 
The results from the evaluation exercise of the modified high-throughput variant of Comet 
assay are summarized in Table 1. Observed LOELs obtained from the modified HT-ACA 
were in good accordance with the standard HT-ACA protocol, albeit some differences were 
revealed. For instance, the modified HT-ACA detected positive genotoxicity in concentrations 
two (B(a)P) to five (DMBA) times lower than earlier had been found with the standard HT-
ACA protocol. Results from the present study are in contrast to the previously published 
evaluation of HT-ACA (Kiskinis et al. 2002), where the dose-response curves were similar 
for both tests but the absolute values for tail moment were lower in the high throughput 
variant (Kiskinis et al. 2002).  
  
It should be noted, however, that even though the modified HT-ACA detected genotoxicity in 
lower concentrations, the dose response-curves tend to become saturated. This is especially 
true in the case of chemicals in need of metabolic activation. The most likely cause for the 
observed saturation for B(a)P and DMBA, seems to be depletion of cofactors or bad S9-mix 
preparation. The presence of proteins during electrophoresis is also known to influence the 
migration of DNA, therefore a remaining protein contamination from the S9-mix can cause a 
saturation of the dose-response curve.  
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Table 1: Data of historical LOELs from the standard HT-ACA protocol (unpublished data, AstraZeneca) and 
LOELs obtained in this study with the modified HT-ACA protocol. 
Direct mutagens (-S9) Historical LOEL 
(mM) 
LOEL  
(mM) 
Parameter 
4-nitroquinoline-N-oxide 
(4NQNO) 
0.00025  
(-S9) 
0.000219  
(-S9)  
Tail moment 
Mitomycin C  
(MMC) 
No effect  
(-S9) 
0.275  
(-S9)  
Cross linking LOEL 
Promutagens (+S9) 
 
Historical LOEL 
(mM) 
LOEL  
(mM) 
Parameter 
Benzo(a)pyrene  
(B(a)P) 
0.00998  
(+S9) 
0.004375  
(+S9) 
Tail length, tail moment, rel. fraction 
of cells with DNA damage 
9,10-dimethyl-1,2-
benzanthracene (DMBA) 
0.02  
(+S9) 
0.00375  
(+S9)  
Tail length, tail moment, rel. fraction 
of cells with DNA damage 
        
7. Summary and future perspectives 
 
The Comet assay has the potential to become a powerful complement to other genotoxicity 
tests during the early drug development. The results of this study showed equivalent or more 
sensitive outcomes for the modified high throughput variant than the standard HT-ACA 
protocol for the Comet assay. Still, there are some bottlenecks in the performance of this 
method and the choice of cytotoxicity test, which need to be addressed.  
 
Cytotoxicity test 
• Cytotoxicity marker - other investigators have concluded that measurements of ATP 
levels may be the more accurate parameter for cytotoxicity. The ATP level is an 
indicator of the functional integrity of living cells and any injury or cell death will lead 
to a corresponding decrease in cytoplasmatic ATP content (Crouch et al. 1993). In the 
case of the traditionally used TBDE method, only cells with a damaged membrane 
will allow uptake of dye and be considered dead. Nevertheless, according to Elia et al. 
certain compounds induce acute cytotoxicity without having an immediate effect on 
membrane integrity. A good thing to keep in mind is that the viability tests measures 
different types of cytotoxicity. Methods should be chosen according to what effect one 
is looking for. The most relevant approach would be to first measure ATP level 
changes in all samples and look for membrane damage with TBDE only in samples 
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with a significant decrease in ATP.  If no significant decrease in ATP levels is present, 
there is probably no relevant cytotoxic damage either.                 
• Reproducibility - when comparing the results from the TBDE method and 
measurement of ATP levels (CellTiter-Glo®) using the generally applied viability 
values, ≥70% (TBDE method) and ≥50% (ATP levels) of the concurrent control, 
almost the same concentrations of the compounds were selected for further analysis in 
the Comet assay. Additional experiments are needed to establish if there is a good 
correlation between the tests.        
 
HT-ACA 
• Type of object slide – with use of multi-well object slides the number of samples that 
can be run at the same time has been greatly increased. At present, the equipment 
available at SAS allows simultaneous run of 21 object slides. 
• Sample wash – samples selected to proceed in the Comet assay were moved from the 
96-well plate to Eppendorf tubes to be washed in PBS. This is a time-requiring step 
posing a serious limitation for the throughput of the method (handling a great number 
of samples, limitations of centrifuge space). Thus, the washing steps should be 
optimized, preferentially using a centrifuge for 96-well plates and a multi-well pipette 
or performed twice. 
• Cell density and focusing – it is rather laborious to find the 50 comets manually and 
adjust focus on the microscope each time. The cell concentration and volume of 
agarose-cell suspension applied per well should be optimized. Proper adjustment of 
the later is especially important in order to bring all the cells, after drying the agarose 
gel, to the same optical plane.  
• Scoring procedure – the capture and evaluation of images would be greatly enhanced 
using a more modern version of the image analysis system. For instance, in the most 
recent version of the Comet assay software (Perceptive Instruments) there is no need 
to position a frame around each comet (from which background values are obtained). 
Here, a “one-click” scoring algorithm is used instead, resulting in increased speed of 
scoring. 
• Evaluation of results – the Excel macros presently used to evaluate Comet assay 
results at SAS are designed to accommodate DNA migration parameters from 21 
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samples. A typical number of samples from a HT-ACA experiment would be around 
70-90. Thus, the Excel macros must be improved.  
• Reproducibility - only one single experiment per chemical was performed by the 
modified HT-ACA protocol.   
• Evaluation criteria – the experiments in this study should be repeated using a 
standardized protocol in order to verify if the evaluation criteria previously developed 
for the standard HT-ACA protocol of the Comet assay can be applied in the modified 
HT-ACA protocol. Furthermore, new criteria must be found for cross-linking 
chemicals to find out when they should be considered as positive.           
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10. Appendix 
1%, 0.6% agarose  0.6% LMP agarose 
Agarose in PBS   LMP agarose in PBS 
 
Cofactor solution for S9-mix pH 7.2 
3.9 mg NADP/mL R0P 
16.7 mg Sodium isocitrate/mL R0P 
 
200 mM EDTA 
EDTA in water 
 
Electrophoresis buffer pH >13 
300 mM NaOH 
1 mM Na2 EDTA 
 
20 μg/mL ethidium bromide 
Ethidium bromide in water 
 
Lysis solution pH 10 
2.5 M NaCl 
100 mM EDTA 
10 mM Trizma-Bas 
 
10% DMSO ⎫ 
1% Triton X-100 ⎬ added before use 
  ⎭ 
 
10M NaOH 
Sodium hydroxide pellets in water 
 
Neutralization buffer pH 7.5 
0.4 M Trizma Base 
 
PSGP 
100 mL 10 000 units/mL penicillin and 10 000 μg/mL streptomycin in 85% saline 
50 mL 200 mM L-Glutamine 
100 mL 100 mM Sodium pyruvate  
 
R10P (cell cultivation media supplemented with 10% serum) 
500 mL RPMI 1640 (Dutch modification without L-Glutamine) 
25 mL PSGP 
5.5 mL Pluronic F68 
55 mL heat inactivated horse serum  
 
R0P (cell cultivation media without serum) 
500 mL RPMI 1640 (Dutch modification without L-Glutamine) 
25 mL PSGP 
5 mL Pluronic F68 
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